Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett C Sheppard

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Cancer Medicine|May 3, 2023
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinomaEmerson Y Chen, Adel Kardosh, Nima Nabavizadeh, et al.
Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Long Noncoding RNAs Preserve Pancreatic Cancer Identity and Resist Cell Fate ConversionDmytro Grygoryev, Seung-Won Lee, Connor Mitchell Frankston, et al.
Cancers|November 9, 2024
Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic CancerRanish K Patel, Michael Parappilly, Hannah C Farley, et al.
Cell Reports|January 17, 2019
Modeling Tumor Phenotypes In Vitro with Three-Dimensional BioprintingEllen M Langer, Brittany L Allen-Petersen, Shelby M King, et al.
Cancers|February 15, 2022
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative ComplicationsChristopher Ryan Deig, Thomas Lee Sutton, Blake Beneville, et al.
Nature Communications|November 25, 2017
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistanceAmy S Farrell, Meghan Morrison Joly, Brittany L Allen-Petersen, et al.
Science Advances|September 15, 2018
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survivalCharles E Gast, Alain D Silk, Luai Zarour, et al.
Scientific Reports|July 2, 2021
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumorsMatthew S Dietz, Thomas L Sutton, Brett S Walker, et al.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Cancer Medicine|May 3, 2023
Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinomaEmerson Y Chen, Adel Kardosh, Nima Nabavizadeh, et al.
Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Long Noncoding RNAs Preserve Pancreatic Cancer Identity and Resist Cell Fate ConversionDmytro Grygoryev, Seung-Won Lee, Connor Mitchell Frankston, et al.
Cancers|November 9, 2024
Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic CancerRanish K Patel, Michael Parappilly, Hannah C Farley, et al.
Cell Reports|January 17, 2019
Modeling Tumor Phenotypes In Vitro with Three-Dimensional BioprintingEllen M Langer, Brittany L Allen-Petersen, Shelby M King, et al.
Cancers|February 15, 2022
Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative ComplicationsChristopher Ryan Deig, Thomas Lee Sutton, Blake Beneville, et al.
Nature Communications|November 25, 2017
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistanceAmy S Farrell, Meghan Morrison Joly, Brittany L Allen-Petersen, et al.
Science Advances|September 15, 2018
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survivalCharles E Gast, Alain D Silk, Luai Zarour, et al.
Scientific Reports|July 2, 2021
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumorsMatthew S Dietz, Thomas L Sutton, Brett S Walker, et al.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Pageof 12